How to decide whether to offer and use "nonstandard" therapies in patients with advanced sarcomas and gastrointestinal stromal tumors: global variations in clinical practice, assessment, and access to therapies in diseases with limited incidence and data.

Sleijfer, Stefan; Judson, Ian; Demetri, George D

Sleijfer, Stefan; Judson, Ian; Demetri, George D.

Afiliação

Sleijfer S; From the Erasmus MC Daniel Den Hoed Cancer Center, Rotterdam, Netherlands; CR UK Centre for Cancer Therapeutics, Sutton, United Kingdom; Ludwig Center and Sarcoma Center, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.
Judson I; From the Erasmus MC Daniel Den Hoed Cancer Center, Rotterdam, Netherlands; CR UK Centre for Cancer Therapeutics, Sutton, United Kingdom; Ludwig Center and Sarcoma Center, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.
Demetri GD; From the Erasmus MC Daniel Den Hoed Cancer Center, Rotterdam, Netherlands; CR UK Centre for Cancer Therapeutics, Sutton, United Kingdom; Ludwig Center and Sarcoma Center, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.

Am Soc Clin Oncol Educ Book ; : 645-50, 2012.

Article em En | MEDLINE | ID: mdl-24451812

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Temas: ECOS / Aspectos_gerais Bases de dados: MEDLINE Tipo de estudo: Incidence_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Am Soc Clin Oncol Educ Book Ano de publicação: 2012 Tipo de documento: Article País de afiliação: Marrocos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google